Andy Pasternak

어드바이저 파트너,



Andy Pasternak is a member of our Healthcare & Life Sciences practice, previously serving as a Senior Partner and leader for the Americas. He was also a member of the Mergers & Acquisitions practice.

Andy has over 25 years of experience as a consultant and an executive. He advises boards of directors, CEOs and their leadership teams on their most pressing business challenges and opportunities.

At Bain, Andy has worked with large pharmaceutical companies, medical technology companies, biotechnology firms, private investment funds, NGOs and government agencies. He holds deep expertise in growth strategy, market entry, competitive strategy, M&A, organizational design and executive/board governance, operational strategy and performance improvement. In the biopharmaceutical space, Andy has worked across a wide range of specialty therapeutic areas (including rare diseases) and functions, including commercial, operations and R&D.

Recently, Andy served as Executive Vice President, Chief Strategy Officer for Horizon Therapeutics, a biotechnology company focused on serious, rare autoimmune diseases. In this role, he was responsible for corporate strategy, M&A / business development, commercial development, and portfolio management, and he played a central role in the $28 billion acquisition of Horizon by Amgen, Inc. in 2023.

Prior to joining Bain in 2008, Andy was a founding partner in the Health & Life Sciences Practice at a global management consultancy. He also worked in the investment banking division of Chemical Bank (now part of JP Morgan).

Andy earned an MBA from the University of Chicago Graduate School of Business and a B.A. in Economics from Northwestern University.

Recent Insights

베인에 궁금하신 점이 있으신가요?

베인은 주저 없이 변화를 마주할 줄 아는 용감한 리더들과 함께합니다. 그리고, 이들의 담대한 용기는 고객사의 성공으로 이어집니다.